Abstract:Purpose: To quantify interfractional anatomical variations and their dosimetric impact during the course of fractionated proton therapy (PT) of prostate cancer and to assess the robustness of the current treatment planning techniques.Methods: Simulation and daily in-room CT scans from ten prostate carcinoma patients were analyzed. PT treatment plans (78 Gy in 39 fractions of 2 Gy) were created on the simulation CT, delivering 25 fractions to PTV1 (expanded from prostate and seminal vesicles), followed by 14 boost fractions to PTV2 (expanded from prostate). Plans were subsequently applied to daily CT, with beams aligned to the prostate center in the sagittal plane. For five patients having a sufficiently large daily imaging volume, structure contours were manually drawn, and plans were evaluated for all CT sets. For the other five patients, the plans were evaluated for six selected fractions. The daily CT was matched to the simulation CT through deformable registration. The registration accuracy was validated for each fraction, and the three patients with a large number of accurately registered fractions were used for dose accumulation.Results: In individual fractions, the coverage of the prostate, seminal vesicles, and PTV1 was generally maintained at the corresponding prescription dose. For PTV2, the volume covered by the fractional prescription dose of 2 Gy (i.e., V2) was, on average, reduced by less than 3% compared to the simulation plan. Among the 225 (39 x 5 + 6 x 5) fractions examined, 15 showed a V2 reduction larger than 5%, of which ten were caused by a large variation in rectal gas, and five were due to a prostate shift in the craniocaudal direction. The fractional dose to the anterior rectal wall was found to increase for one patient who had large rectal gas volume in 25 of the 39 fractions, and another who experienced significant prostate volume reduction during the treatment. The fractional bladder dose generally increased with decreasing fullness. In the total accumulated dose for the three patients after excluding a few fractions with inaccurate registration due to a large amount of rectal gas (a condition inconsistent with RTOG protocol), 98.5%, 96.6%, and 98.2% of the PTV2 received the prescription dose of 78 Gy. The V75 and V70 of the anterior rectal wall and bladder both remained within tolerance.Conclusions: The results confirm that the PT planning techniques and dose constraints used at our institution ensure that target coverage to the prescription dose is maintained in the presence of interfractional anatomical variations. Dose coverage in individual fractions can be compromised, and normal tissue dose increased, due to deviations in the bladder and rectal volume compared to the simulation plans or progressive changes in the prostate volume during the treatment. Deviations from the plan can be reduced with efforts aimed at maintaining consistent daily patient anatomy. (C) 2011 American Association of Physicists in Medicine. [DOI: 10.1118/1.3604152]

Evaluation of Interfraction Setup Uncertainty of GBM Patients Wearing TTFields (tumor treating fields) during Radiotherapy

Postoperative Radiotherapy For Glioma: Improved Delineation Of The Clinical Target Volume Using The Geodesic Distance Calculation

SU-GG-J-109: A Study on Image Guided Radiotherapy Using Cone-Beam Computed Tomography (CBCT) for Head and Neck Cancer IMRT Patient Setup

Innv-26. Feasibility Evaluation Of Tumor Treating Fields (Ttfields) Therapy For Brainstem Gliomas

Preliminary study of feasibility of surface-guided radiotherapy with concurrent tumor treating fields for glioblastoma: region of interest

Evaluation Of The Dosimetric Impact Of Interfractional Anatomical Variations On Prostate Proton Therapy Using Daily In-Room Ct Images

Inter- and intrafractional setup errors and baseline shifts of fiducial markers in patients with liver tumors receiving free-breathing postoperative radiation analyzed by cone-beam computed tomography.

Radt-13. Real-World Data On Newly Diagnosed Who 4 Gliomas Undergoing Ttfields: Survival Analysis And Relapse Patterns From A Single Center

Effects of tumor treating fields (TTF) arrays on the radiation doses to glioblastoma

Evaluating the positional uncertainty of intrafraction, adjacent fields, and daily setup with the BrainLAB ExacTrac system in patients who are receiving craniospinal irradiation.

Megavoltage cone-beam CT in the evaluation of set-up errors in head and neck cancers treated with precision radiotherapy

RETROSPECTIVE ANALYSIS OF USING RADIOTHERAPY WITH CONCURRENT TEMOZOLOMIDE AND TUMOR TREATING FIELDS FOR CHINESE PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA

Interfractional and Intrafractional Errors in Radiotherapy of Lung Cancer Using Cone-beam Computed Tomography (CBCT)

The Effect Of Image-Guided Radiation Therapy On The Margin Between The Clinical Target Volume And Planning Target Volume In Lung Cancer

[Interfractional and Intrafractional Setup Errors in Radiotherapy for Tumors Analyzed by Cone-Beam Computed Tomography].

Theory and application of TTFields in newly diagnosed glioblastoma

Intrafraction variation of mean tumor position during image-guided hypofractionated stereotactic body radiotherapy for lung cancer

Does the protocol-required uniform margin around the CTV adequately account for setup inaccuracies in whole breast irradiation?

Tumor treating fields in glioblastoma: long-term treatment and high compliance as favorable prognostic factors

Correlation of Tumor Treating Fields Dosimetry to Survival Outcomes in Newly Diagnosed Glioblastoma: A Large-Scale Numerical Simulation-Based Analysis of Data from the Phase 3 EF-14 Randomized Trial

SU-FF-J-39: Image Guided Radiation Therapy: Investigation of Interfraction Setup and External Contour Variation for Prostate IMRT Using CT and MRI